Resistance to TGF-β1-mediated growth inhibition correlates with sustained Smad2 phosphorylation in primary murine splenocytes

European Journal of Immunology

Volumn 32, Issue 5, 2002, Pages 1393-1402

  Feldmann, Kristina ^a   Sebald, Walter ^a   Knaus, Petra ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cytotoxicity; Smad2; T cell; TGF 1

Indexed keywords

CD8 ANTIGEN; SMAD PROTEIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN; SMAD3 PROTEIN, MOUSE; SMAD4 PROTEIN; SMAD4 PROTEIN, MOUSE; TGFB1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; GROWTH INHIBITION; IMMUNE RESPONSE; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PURIFICATION; SPLEEN CELL; TUMOR GROWTH; ANIMAL; CELL CULTURE; CELL DIVISION; CHEMISTRY; CYTOLOGY; CYTOTOXICITY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE;

ANIMALS; CELL DIVISION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; MICE; PHOSPHORYLATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SPLEEN; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0036001052     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200205)32:5<1393::AID-IMMU1393>3.0.CO;2-M     Document Type: Article

References (45)

1. TGF-β: Biological function and chemical structure
2. The TGF-β family
3. Regulation of immune responses by TGF-β
4. Production of TGF-β by human T-lymphocytes and its potential role in the regulation of T cell growth
5. Targeted disruption of the mouse TGF-β1 gene results in multifocal inflammatory disease
6. TGF-β1 null mutation in mice causes excessive inflammatory response and early death
7. Loss of functional cell surface TGF-β type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia
8. A dominant inhibitory mutant of the type II TGF-β receptor in the malignant progression of a cutaneous T cell lymphoma
9. TGF-beta: A balancing act
10. TGF-beta signaling from cell membrane to nucleus through SMAD proteins
11. TGF-beta signal transduction
12. TGF-beta signals through a heteromeric protein kinase receptor complex
13. Type III TGF-beta receptor-independent signaling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-β type II receptor
14. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by TGF-β1
15. Human ex vivo carcinoma cells produce TGF-β and thereby can inhibit lymphocyte functions in vitro
16. TGF-β from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T-lymphocytes
17. TGF-β secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon gamma and tumor necrosis factor production of active TGF-β
18. Co-stimulation of T cell proliferation by TGF-β1
19. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative TGF-β II receptor
20. + Th1/Th2 T cells
21. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for TGF-β and activin-A
22. Molecular cloning of two CD7 (T cell leukemia antigen) cDNAs by a COS cell expression system
23. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells
24. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4
25. DPC4 (SMAD4) mediates TGF-β1 induced growth inhibition and transcriptional response in breast tumour cells
26. TGF-β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGF-β signal transduction during transdifferentiation cells
27. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
28. Role of TGF-β in human disease
29. Down-regulation of interleukin-12 (IL-12) responsiveness in human T cells by TGF-β: Relationship with IL-12 signaling
30. TGF-β differentially regulates IL-2 expression and [3H]thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes
31. Control of CD4 effector fate: TGF-β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion
32. TGF-β alters APC preference, polarizing islet antigen responses toward a Th2 phenotype
33. On the mechanisms by TGF-β2 alters antigen-presenting abilities of macrophages on T cell activation
34. CD28 and apoptosis
35. + T cells by TGF-β1
36. T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells
37. + T-lymphocytes. Inhibition by TGF-β
38. Inhibition of cytotoxic T cell development by TGF-β and reversal by recombinant tumor necrosis factor alpha
39. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase
40. Ubiquitin-dependent degradation of TGF-β-activated smad2
41. Ligation of the T cell receptor complex results in phosphorylation of Smad2 in T-lymphocytes
42. Signaling of TGF-β family members through smad proteins
43. The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses
44. TGF-β-independent shuttling of Smad4 between the cytoplasm and nucleus
45. Eukaryotic gene transcription with purified components